Teva's Respiratory Drugs Contribute 11% to Specialty Medicines
Shop Teva Respiratory Agents - McKesson Medical-Surgical
Top 20 Global Respiratory Inhalers Manufacturers 2019 - Visiongain Research
Teva launches first U.S. generic Perforomist inhaled COPD treatment - Drug Delivery Business
Teva launches breath-activated asthma aerosol in U.S. - Drug Delivery Business
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
FDA Approves Teva's ProAir Digihaler for Asthma, COPD | RT
HealthSnap
Teva Canada Announces the Launch of (Pr)Teva-Tobramycin Inhalation Solution, a Generic of (Pr)Tobi®
Teva USA
Teva's Asthma Segment: What Could Boost Its Revenues in 2016?
Teva Pharmaceuticals and IBM Expand Global Partnership to Enable Drug Development and Chronic Disease Management with Watson
Complex Generics Made Simple — the Respiratory Segment | Teva api
Teva Pharmaceuticals buys smart inhaler company Gecko Health Innovations | MobiHealthNews
The World of the API Podcast: Respiratory APIs | Teva api
Teva Reports First Quarter 2020 Financial Results | Business Wire
Teva Respiratory launches AirDuo Digihaler, ArmonAir Digihaler | Drug Store News
Teva Pharmaceuticals no LinkedIn: Explore the burden of chronic respiratory diseases and the future of…
Teva's Unorthodox Strategy For The Respiratory Market — Will It Work
Teva Pharmaceutical Industries Ltd (TEVA) Reports Solid Growth in 2023 Earnings
Teva Pharmaceuticals To Buy Gecko Health Innovations
Teva Launches AirDuo Respiclick and Authorized Generic - Drug Discovery and Development
Teva launches AirDuo RespiClick, generic inhaled asthma therapies - Drug Delivery Business
FDA approves Teva's biosimilar for neutropaenia in cancer patients - PMLiVE
Teva | Contract Pharma
